Comprehensive Clinical Development

Washington D.C., District of Columbia 20016

0 studies enrolling now · 5 studies all time

What they study most

Mental Disorder, Nervous System Diseases, Schizoaffective Disorder, Schizophrenia

Studies at this site

• A Study to Investigate the Efficacy, Safety and Tolerability of Four Different Doses of BI 409306 Compared to Placebo Given for 12 Weeks in Patients With Schizophrenia on Stable Antipsychotic Treatment. — Completed
• An Outpatient Study Of The Efficacy, Safety, And Tolerability Of PF-02545920 In The Adjunctive Treatment Of Sub-Optimally Controlled Symptoms of Schizophrenia — Stopped early
• Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia — Completed
• Bioavailability of LY03004 and Risperdal® Consta® — Completed
• Safety and Tolerability Trial of Aripiprazole IM Depot Treatment in Adult Subjects With Schizophrenia Stabilized on Oral Antipsychotics Other Than Aripiprazole — Completed